Related Experiment Video

Updated: Feb 21, 2026

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

2.4K

Are we ready to take full advantage of patient-derived tumor xenograft models?

Peter W Kyriakides1, Giorgio Inghirami1,2,3

  • 1Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.

Hematological Oncology
|May 26, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

8.0K
A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

13.3K

Related Concept Videos